NCT02755220View on ClinicalTrials.gov

Cingularbio® Heart Valve Clincial Study

NACompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

April 30, 2019

Conditions
Diseases of Mitral and Aortic Valves
Interventions
DEVICE

Cingularbio® Aortic valve replacement

the patients will be replaced by Cingularbio heart valve

Trial Locations (5)

200032

Zhongshan Hospital of Fudan University, Shanghai

Unknown

Cardiale Heelkunde, Leuven

Klinika Kardiochirurgii, Katowice

Klinika Kardiochirurgii, Krakow

Klinika Kardiochirurgii, Warsaw

All Listed Sponsors
lead

Shanghai Cingularbio Co. Ltd

INDUSTRY

NCT02755220 - Cingularbio® Heart Valve Clincial Study | Biotech Hunter | Biotech Hunter